CHST12
Carbohydrate sulfotransferase 12
Also known as: C4S-2, C4ST2, CHSTC_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NRB3
- Gene
- CHST12
- Ensembl
- ENSG00000136213
- Chromosome
- 7
- Canonical length
- 414 aa
- Protein class
- Enzymes, Metabolic proteins, Predicted membrane proteins
- Subcellular location
- Golgi apparatus
OverviewNCBI Gene
The protein encoded by this gene belongs to the sulfotransferase 2 family. It is localized to the golgi membrane, and catalyzes the transfer of sulfate to position 4 of the N-acetylgalactosamine (GalNAc) residue of chondroitin and desulfated dermatan sulfate. Chondroitin sulfate constitutes the predominant proteoglycan present in cartilage, and is distributed on the surfaces of many cells and extracellular matrices. Alternatively spliced transcript variants differing only in their 5' UTRs have been found for this gene. [provided by RefSeq, Aug 2011]
Canonical amino-acid sequenceUniProt
414 residues, UniProt reviewed canonical sequence.
>Q9NRB3|CHST12
1 MTKARLFRLW LVLGSVFMIL LIIVYWDSAG AAHFYLHTSF SRPHTGPPLP TPGPDRDREL
61 TADSDVDEFL DKFLSAGVKQ SDLPRKETEQ PPAPGSMEES VRGYDWSPRD ARRSPDQGRQ
121 QAERRSVLRG FCANSSLAFP TKERAFDDIP NSELSHLIVD DRHGAIYCYV PKVACTNWKR
181 VMIVLSGSLL HRGAPYRDPL RIPREHVHNA SAHLTFNKFW RRYGKLSRHL MKVKLKKYTK
241 FLFVRDPFVR LISAFRSKFE LENEEFYRKF AVPMLRLYAN HTSLPASARE AFRAGLKVSF
301 ANFIQYLLDP HTEKLAPFNE HWRQVYRLCH PCQIDYDFVG KLETLDEDAA QLLQLLQVDR
361 QLRFPPSYRN RTASSWEEDW FAKIPLAWRQ QLYKLYEADF VLFGYPKPEN LLRDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CHST12 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.32
- Highest tissue expression
- 19 nTPM
Expression across tissuesHPA
Tissue
- spleen: 19 nTPM
- endometrium: 14 nTPM
- adipose tissue: 13 nTPM
- fallopian tube: 13 nTPM
- heart muscle: 13 nTPM
- pituitary gland: 13 nTPM
Single-cell type
- syncytiotrophoblasts: 157 nCPM
- nk-cells: 148 nCPM
- cytotrophoblasts: 134 nCPM
- leydig cells: 106 nCPM
- decidual stromal cells: 105 nCPM
- plasma cells: 90 nCPM
Immune cell
- NK-cell: 122 nTPM
- gdT-cell: 88 nTPM
- memory CD8 T-cell: 71 nTPM
- plasmacytoid DC: 65 nTPM
- basophil: 59 nTPM
- MAIT T-cell: 55 nTPM
Brain region
- medulla oblongata: 37 nTPM
- hippocampal formation: 36 nTPM
- cerebellum: 32 nTPM
- thalamus: 30 nTPM
- midbrain: 28 nTPM
- cerebral cortex: 27 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.28
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.15
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- carbohydrate biosynthetic process
- chondroitin sulfate proteoglycan biosynthetic process
- dermatan sulfate proteoglycan biosynthetic process
- proteoglycan biosynthetic process
Molecular functions
- 3'-phosphoadenosine 5'-phosphosulfate binding
- chondroitin 4-sulfotransferase activity
- sulfotransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CHST12 as an antibody target. Whether an autoantibody or antibody against CHST12 could matter depends on whether native CHST12 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CHST12 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label CHST12 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...